Showing results (751-760 of 803) with videos related to

Sort By:
Pageof 81
American Heart Journal|March 18, 2020
Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillationFrederik Dalgaard, Rebecca North, Karen Pieper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2008
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trialEdith A Perez, Vera J Suman, Nancy E Davidson, et al.
Clinical Cardiology|August 19, 2023
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registriesToon Wei Lim, Alan John Camm, Saverio Virdone, et al.
Heart (British Cardiac Society)|February 17, 2021
Comparative effectiveness of oral anticoagulants in everyday practiceA John Camm, Keith A A Fox, Saverio Virdone, et al.
Circulation. Arrhythmia and Electrophysiology|November 17, 2017
Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation)Adam S Barnett, Sunghee Kim, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|February 16, 2018
New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL TrialIoanna Kosmidou, Shmuel Chen, A Pieter Kappetein, et al.
Journal of the American Heart Association|April 27, 2019
Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF RegistryAlexander C Perino, Peter Shrader, Mintu P Turakhia, et al.
JAMA Network Open|February 27, 2020
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial FibrillationKeith A A Fox, Priscilla Velentgas, A John Camm, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 20, 2026
Time-Critical Cardiovascular Risk After COVID-19: A Population-Based Analysis Across Variant ErasJames F Howick V, Bernard J Gersh, Christopher G Scott, et al.
Circulation. Heart Failure|April 12, 2013
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trialJohn J V McMurray, Justin A Ezekowitz, Basil S Lewis, et al.
Pageof 81